Core Promoter and Pre-Core Variants of the Hepatitis B Virus (HBV) Are Frequent in Chronic Hepatitis B HBeAg-Negative Patients Infected by Genotypes A and D

被引:0
|
作者
Reuter, Tania [1 ,2 ]
Gomes-Gouvea, Michele Soares [2 ]
Chuffi, Samira [2 ]
Duque, Ulisses Horst [1 ]
Perini, Waltesia [1 ]
Azevedo, Raymundo Soares [3 ]
Pinho, Joao Renato Rebello [2 ,4 ,5 ]
Lewis-Ximenez, Lia L.
Villar, Livia Melo
Espul, Carlos Alberto
Pujol, Flor H.
Roman, Sonia
机构
[1] Univ Fed Espirito Santo, Univ Hosp Cassiano Antonio de Moraes, Hlth Sci Ctr, Internal Med Dept, BR-29041295 Vitoria, ES, Brazil
[2] Univ Sao Paulo, Sch Med, Inst Trop Med, Dept Gastroenterol,LIM 07, BR-05403907 Sao Paulo, SP, Brazil
[3] Univ Sao Paulo, Sch Med, Dept Pathol, BR-01246903 Sao Paulo, SP, Brazil
[4] Hosp Israelita Albert Einstein, Clin Lab, BR-05652900 Sao Paulo, SP, Brazil
[5] Univ Sao Paulo, Clin Hosp, Sch Med, Cent Labs Div,LIM 03, BR-05403000 Sao Paulo, SP, Brazil
来源
VIRUSES-BASEL | 2023年 / 15卷 / 12期
关键词
chronic hepatitis B; HBV; pre core mutations; basal core promoter mutations; BCP and PC variants; MUTATIONS; BRAZIL;
D O I
10.3390/v15122339
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In Brazil, hepatitis B virus endemicity is low, moderate, or high in some areas, such as Espirito Santo State in the southeast region. In this study, we intend to characterize the basal core promoter (BCP) and pre-core region (PC) variants and their association with clinical/epidemiological disease patterns in patients infected with genotypes A and D. The study included 116 chronic hepatitis B patients from Espirito Santo State, Southeast Brazil, infected with genotypes A and D. Basal core promoter (BCP) and pre-core mutations were analyzed in these patients. The frequency of BCP and PC mutations was compared with age, HBeAg status, HBV genotype and subgenotype, HBV-DNA level, clinical classification, and transmission route. HBeAg-negative status was found in 101 (87.1%) patients: 87 (75.0%) were infected with genotype A (A1 = 85; A2 = 2) and 29 (25.0%) were infected with genotype D (D3 = 24; D4 = 3; D2 = 2). BCP + PC variants altogether were more frequent (48.1%) in genotype D than in genotype A strains (6.0%) (p < 0.001). When this evaluation was performed considering the cases that presented only the A1762T and/or G1764A (BCP) mutations, it was observed that the frequency was higher in genotype A (67.5%) compared to genotype D (7.4%) (p < 0.001). On the other hand, considering the samples with mutations only in positions G1896A and/or G1899A (PC), the frequency was higher in genotype D (75.8%) than in genotype A (6.9%) (p < 0.001). Interestingly, HBV DNA was lower than 2000 IU/mL especially when both BCP/PC mutations were present (p < 0.001) or when only PC mutations were detected (p = 0.047), reinforcing their role in viral replication.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Treatment of HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Papatheodoridis, GV
    Vassilopoulos, D
    SEMINARS IN LIVER DISEASE, 2003, 23 (01) : 81 - 88
  • [42] Clinical and virological aspects of core and pre-core mutations in three generations of chronic hepatitis B virus patients
    Naderi, Malihe
    Hosseini, Seyed Masoud
    Besharat, Sima
    Behnampour, Naser
    Shahramian, Iraj
    Moradi, Abdolvahab
    FUTURE VIROLOGY, 2023, 18 (06) : 349 - 358
  • [43] The role of pre-core hepatitis B virus (HBV) nt 1896 mutant on acute and chronic hepatitis B in Sao Paulo, Brazil.
    Pacheco, MS
    Palumbo, MN
    Tanaka, TT
    Perez, RM
    Al Matos, C
    Pace, FH
    Lanzoni, VP
    Ferraz, ML
    Silva, AE
    HEPATOLOGY, 2000, 32 (04) : 465A - 465A
  • [44] Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants
    Hussain, M
    Chu, CJ
    Sablon, E
    Lok, ASF
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) : 3699 - 3705
  • [45] Associations of Hepatitis B Virus (HBV) Pre-Core (PC) and Basal Core Promoter(BCP) Mutations with the Risk of Hepatocellular Carcinoma (HCC)
    Wang, Chunping
    Wang, Hong
    Xu, Dongping
    Qu, Jianhui
    Yang, Yongping
    Hu, Ke-Qin
    HEPATOLOGY, 2012, 56 : 435A - 436A
  • [46] Diagnosis and management of pre-core mutant chronic hepatitis B
    Papatheodoridis, GV
    Hadziyannis, SJ
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (05) : 311 - 321
  • [47] Clinical significance of hepatitis B virus DNA levels in HBeAg-negative, HBV genotype D-infected patients.
    Germanidis, G
    Roudot-Thoraval, F
    Guerre, F
    Miladi, A
    Bouvier-Alias, M
    Makri, I
    Manolakopoulos, S
    Pagkalos, E
    Avgerinos, A
    Dalekos, G
    Pawlotsky, JM
    HEPATOLOGY, 2004, 40 (04) : 675A - 675A
  • [48] What does the hepatitis B virus DNA level tell us in HBeAg-negative patients infected with hbv genotype D?
    Germanidis, G
    Chevaliez, S
    Roudot-Thoraval, F
    Bouvier-Alias, M
    Guerre, F
    Miladi, A
    Makri, I
    Manolakopoulos, S
    Pagkalos, E
    Avgerinos, A
    Dalekos, G
    Pawlotsky, JM
    JOURNAL OF HEPATOLOGY, 2005, 42 : 177 - 177
  • [49] Hepatitis B virus DNA suppression with entecavir therapy in a HBeAg-negative decompensated chronic HBV
    Muneer, Badar
    Mohanty, Smruti R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S242 - S242
  • [50] Treatment paradigms in hepatitis B e antigen negative (HBeAg-negative) chronic hepatitis B patients
    Hadziyannis, S. J.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S15 - S15